Harsha S Prakash

Employment

Employment history is unavailable.

Education

• All India Institute of Medical Sciences Rishikesh DM
  2025 - 2027
• JIPMER MD
  2021 - 2023
• Mysore Medical College & Research Institute MBBS
  2014 - 2020

Projects & Funding

Projects & funding information is unavailable.

Publications (11)

• High-risk gestational trophoblastic neoplasia presenting with seizures and bilateral visual loss years after pregnancy in the absence of a uterine lesion
  BMJ Case Reports 2026 DOI: 10.1136/bcr-2026-276099
  +Save
• Translation of the strength, assistance in walking, rising from a chair, climbing stairs, and falls questionnaire into Hindi
  Harsha S. Prakash, Amit Sehrawat, Arti Rana +4 more
  World Journal of Methodology 2026 DOI: 10.5662/wjm.120002
  +Save
• Feasibility and safety of accelerated MVAC (aMVAC) in geriatric patients with muscle-invasive bladder cancer
  Sai Prasath, Deepak Sundriyal, Harsha S. Prakash

  +7 more

  • Anusha Mruthyunjaya Swamy
  • Karthik Jayalingappa
  • Mayank Kapoor
  • Mahesh koulagi
  • Vikas Kumar Panwar
  • +2 more
  Medical Oncology 2026 DOI: 10.1007/s12032-026-03361-z
  +Save
• Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin for Muscle-Invasive Bladder Cancer: Real-World Feasibility and Safety in a Resource-Constrained Setting
  Deepak Sundriyal, Sai Prasath, Harsha S. Prakash +9 more
  JCO Global Oncology 2026 DOI: 10.1200/GO-26-00219
  +Save
• 358P First-line treatment patterns and outcomes in advanced and metastatic gallbladder cancer: A real-world experience from India
  Amit Sehrawat, Harsha S. Prakash, Saiprasath Janaarthanan +6 more
  Annals of Oncology 2026 DOI: 10.1016/j.annonc.2026.05.398
  +Save
• 367P Real-world outcomes with first-line gemcitabine–oxaliplatin (GEMOX) in advanced and metastatic gallbladder Cancer (GBC): A retrospective analysis from India
  Harsha S. Prakash, Amit Sehrawat, Anusha Mruthyunjaya Swamy +5 more
  Annals of Oncology 2026 DOI: 10.1016/j.annonc.2026.05.407
  +Save
• Tolerance of gemcitabine–oxaliplatin (GEMOX) in advanced and metastatic gallbladder cancer: A real-world, single-center retrospective study from north India.
  Journal of Clinical Oncology 2026 DOI: 10.1200/jco.2026.44.16_suppl.e16224
  +Save
• Rechallenge-Confirmed Severe Periorbital Edema Following Sunitinib Therapy in Metastatic Renal Cell Carcinoma
  Harsha S. Prakash, Sai Prasath, Deepak Sundriyal +1 more
  Indian Journal of Surgical Oncology 2026 DOI: 10.1007/s13193-026-02622-7
  +Save
• Occult breast carcinoma presenting as isolated vertebral metastasis with negative PET-CT but detected on contrast-enhanced MRI: A case report
  Ekakshi Varshney, Anjum Syed, Abhishek Gupta

  +2 more

  • Sai Prasath
  • Harsha Sp
  Radiology Case Reports 2026 DOI: 10.1016/j.radcr.2026.02.003
  +Save
• Refining early detection of hepatocellular carcinoma: The promise of the GALAD score
  Harsha S. Prakash, Amit Sehrawat, Anusha Mruthyunjaya Swamy +1 more
  World Journal of Gastroenterology 2026 DOI: 10.3748/wjg.v32.i7.115044
  +Save
• Revisiting the use of steroids in oncology
  Sai Prasath, Harsha S. Prakash, Anusha Mruthyunjaya Swamy +5 more
  Medical Oncology 2025 DOI: 10.1007/s12032-025-03214-1
  +Save